Patent Category: Therapies

Application of naringenin and naringenin-containing preparation, and method for slowing, counteracting and preventing the process of formation of albinotic spots on skin

01.09.2020

The patent application relates to the use of naringenin in an effective amount for slowing, counteracting and preventing the process offormation of albinotic spots on skin. The patent application also relates to a preparation containing naringenin in an effective amount as the active ingredient and cosmetically acceptable excipients, vehicle and additives, for use in slowing, counteracting and preventing the process formation of albinotic spots on skin and also relates to a method of ...

3-dodecylsulfanyl-butyric acid to be used as a medicine, preferably to prevent development of insulin immunity and the composition containing 3-dodecylsulfanyl-butyric acid as active substance

01.09.2020

A subject of the invention is a compound 3-dodecylsulfanyl-butyric acid for use as a drug, especially for use in the treatment and prevention of the development of insulin resistance. The ...

8-(octadecylsulfanyl)quinoline for use as a drug, especially for use in the treatment and prevention of the development of insulin resistance

01.09.2020

A subject of the invention is a compound 8-(octadecylsulfanyl)quinoline for use as a drug, especially for use in the treatment and prevention of the development of insulin resistance. The ...

Compositions and methods for treating glioma

01.09.2020

The invention concerns isolated peptides, compositions and methods of use for treating tumors infiltrated with macrophages, such as glioblastomas. GLIA Sp. z o.o. was the leader of patent ...

Mutant strains of Escherichia coli, a method of testing potential antibacterial agents using said strains as well as a testing kit

01.09.2020

The subject of the present invention are mutant strains of Escherichia coli MG6165 (ATCC nr 47076) lacking all potassium transporters: Kdp, Kup and Trk (?Ktrans), encompassing strains lacking at ...